Got $4,000? 4 Game-Changing Stocks to Buy in 2021
Few companies in the drug-development space have offered game-changing potential for their patients quite like Vertex Pharmaceuticals (NASDAQ: VRTX). While all eyes are on COVID-19 vaccine stocks, Vertex is simply dominating the treatment landscape for cystic fibrosis (CF) -- a genetic disease characterized by thick mucus production that can obscure the lungs and pancreas. Although CF doesn't have a cure, Vertex has brought to market a number of gene-based treatments that are improving lung function and quality of life for CF patients.
